SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-12-012959
Filing Date
2012-03-05
Accepted
2012-03-05 17:17:52
Documents
5
Period of Report
2012-04-27
Effectiveness Date
2012-03-05

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A v304065_def14a.htm DEF 14A 623812
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC v304065_pc1.jpg GRAPHIC 79039
5 GRAPHIC v304065_pc2.jpg GRAPHIC 97877
  Complete submission text file 0001144204-12-012959.txt   869387
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10113 | Film No.: 12667558
SIC: 2834 Pharmaceutical Preparations